Axsome Therapeutics, Inc. (AXSM)
145.22
-2.34
(-1.59%)
USD |
NASDAQ |
Dec 09, 16:00
145.19
-0.03
(-0.02%)
After-Hours: 06:52
Axsome Therapeutics Market Cap: 7.321B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.549B |
| Fortress Biotech, Inc. | 88.15M |
| TG Therapeutics, Inc. | 4.831B |
| Karyopharm Therapeutics, Inc. | 108.96M |
| Viking Therapeutics, Inc. | 4.214B |
Market Cap Related Metrics
| PS Ratio | 12.73 |
| Price to Book Value | 99.30 |
| Price | 145.22 |
| Earnings Yield | -3.22% |